Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
37%

OVERLAP
BY WEIGHT
14

# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
26%
ALSO IN HRTS
HRTS
43
HOLDINGS
33%
ALSO IN CANC
SECTOR DRIFT (CANC minus HRTS)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in HRTS
Overlap
ELI LILLY & CO 5.1% 10.4% 5.1%
ASTRAZENECA PLC 4.3% 4.2% 4.2%
ROCHE HOLDINGS LTD-SPONS ADR 3.9% 4.7% 3.9%
JOHNSON & JOHNSON 3.2% 3.2% 3.2%
NOVARTIS AG 4.1% 2.9% 2.9%
CANC Overweight Relative to HRTS
REVOLUTION MEDICINES, INC. 4.1%
COGENT BIOSCIENCES INC 3.9%
GENMAB A/S SPONSORED ADR 3.8%
NUVALENT, INC. CLASS A 3.3%
EXELIXIS INC 3.1%
CELCUITY INC. 2.5%
ARCELLX, INC. 2.5%
BEIGENE LTD. SPONSORED ADR 2.2%
BRIDGEBIO PHARMA, INC. 2.1%
IDEAYA BIOSCIENCES, INC. 2.1%
CANC Underweight Relative to HRTS
ELI LILLY & CO -5.3%
UNITEDHEALTH GROUP INC -4.4%
ABBOTT LABORATORIES -3.7%
THERMO FISHER SCIENTIFIC INC -3.5%
BOSTON SCIENTIFIC CORP -3.1%
MEDTRONIC PLC -3.0%
VERTEX PHARMACEUTICALS INC -2.8%
DANAHER CORP -2.7%
NOVO NORDISK A/S-B -2.5%
ARROWHEAD PHARMACEUTICALS, INC. -2.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY